Amgen Inc. (AMGN)
NASDAQ · Healthcare
Amgen Inc. Shareholder Equity 2007–2025
Amgen Inc. annual shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Amgen Inc. shareholder equity as of December 31, 2025: 8.66B, a 47.32% increase year-over-year.
- Amgen Inc. shareholder equity for 2025 were 8.66B, a 47.32% increase from 2024.
- Amgen Inc. shareholder equity for 2024 were 5.88B, a 5.70% decrease from 2023.
- Amgen Inc. shareholder equity for 2023 were 6.23B, a 70.23% increase from 2022.
- Amgen Inc. shareholder equity for 2022 were 3.66B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Amgen Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $8,658 |
| 2024 | $5,877 |
| 2023 | $6,232 |
| 2022 | $3,661 |
| 2021 | $6,700 |
| 2020 | $9,409 |
| 2019 | $9,673 |
| 2018 | $12,500 |
| 2017 | $25,241 |
| 2016 | $29,875 |
| 2015 | $28,083 |
| 2014 | $25,778 |
| 2013 | $22,096 |
| 2012 | $19,060 |
| 2011 | $19,029 |
Amgen Inc. Shareholder Equity — FAQ
Amgen Inc. (AMGN) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMGN's shareholder equity history?
The chart and table above show Amgen Inc.'s shareholder equity by year and by quarter, including the growth rate.